Try our Advanced Search for more refined results
Mergers & Acquisitions
-
November 10, 2025
Sunnova Ch. 11 Wind-Down Approved Over Release Objection
The Chapter 11 liquidation plan of solar panel company Sunnova Energy International received bankruptcy court approval Monday in Texas after a judge overruled objections to third-party releases raised by the U.S. Trustee's Office.
-
November 10, 2025
PE Firm Investindustrial Inks $2.9B Deal For TreeHouse Foods
Private equity firm Investindustrial has struck a deal to acquire food manufacturer TreeHouse Foods Inc. for $2.9 billion in an all-cash transaction that will take the company private, the two companies announced Monday.
-
November 10, 2025
Chancery Drops Claims In Murder-Linked Bio Co. Merger Fight
The Delaware Chancery Court dismissed a biotech company's claims against the husband and investment vehicle of convicted fraudster Serhat Gumrukcu, whose murder-for-hire plot allegedly helped conceal past misconduct ahead of a 2018 merger.
-
November 10, 2025
Catching Up With Delaware's Chancery Court
Delaware's top court issued a flurry of rulings last week and heard arguments on recently passed legislation that expanded liability shields for some corporate acts while the Court of Chancery passed on another round of arguments over control of Caribbean broadcaster Caribevision.
-
November 10, 2025
Clifford Chance Steers Permira's £2.3B Bid For JTC
Fund administrator JTC PLC said Monday that it has backed a £2.3 billion ($3 billion) cash offer from British private equity shop Permira, as it becomes the latest London-listed company to be taken private.
-
November 07, 2025
Delaware Fee Inflation Worries Overblown, Study Says
A newly published report by two Stanford University researchers asserts that high-dollar attorney fee awards in Delaware courts make up "a very small minority of cases" and are "no basis for concern," throwing cold water on growing worries about so-called fee inflation in the First State.
-
November 07, 2025
Spurned Pfizer Turns To Antitrust Law To Reclaim Biotech
What may be a first-of-its-kind lawsuit is playing out as Pfizer Inc. turns to antitrust law to keep Novo Nordisk from usurping its bid for Metsera.
-
November 07, 2025
9th Circ. Pushed To Revive Suit Over $3.8B Failed Tech Merger
A California federal judge erred in finding that investors in semiconductor company MaxLinear Inc. had no standing to sue it over what they say were misrepresentations about a $3.8 billion merger plan with chipmaker Silicon Motion Technology Corp., they told the Ninth Circuit in a bid to revive their suit.
-
November 07, 2025
Javice Tells Chancery JPMorgan Is Stalling Appeal Fees
Charlie Javice, the convicted founder of college financial aid startup Frank, has told a Delaware judge that JPMorgan Chase & Co. is effectively trying to cut off her ability to appeal her criminal conviction by refusing to advance the vast majority of her ongoing legal fees.
-
November 07, 2025
3 Firms Guide Dubai Hookah Maker's $1.75B SPAC Merger
Three law firms are guiding Dubai hookah brand owner AIR Ltd. on its agreement to go public in the U.S. through a $1.75 billion deal with blank-check firm Cantor Equity Partners III, the companies said on Friday.
-
November 07, 2025
Beauty Co. Says Ex-Exec's $40M Claim 'Implausible'
The former president of a Connecticut beauty brand that L'Oréal bought for around $1 billion has made an "implausible" claim that she is owed $40 million from the sale based on an alleged verbal contract, the company said in opposing her application for a prejudgment remedy.
-
November 07, 2025
Trump Media Q3 Loss Widens On Rising Legal Costs
Truth Social operator Trump Media & Technology Group Corp. on Friday reported larger third-quarter losses than in the year prior due to growing legal expenses related to a special purpose acquisition company merger that took President Donald Trump's media company public last year.
-
November 07, 2025
Taxation With Representation: Kirkland, Cravath, Paul Weiss
In this week's Taxation With Representation, consumer products giant Kimberly-Clark acquires Tylenol maker Kenvue, shale producers SM Energy and Civitas Resources announce a merger, and power management company Eaton buys Boyd Corp.'s thermal business.
-
November 07, 2025
Papa John's CEO Addresses 'M&A Rumors' In Q3 Call
Days after private equity giant Apollo was said to have pulled a roughly $2.1 billion offer to purchase Papa John's, CEO Todd Penegor said Friday that the pizza chain would "fully consider" future strategic alternatives.
-
November 07, 2025
Laborie Buys Postpartum Bleeding Device For Up To $465M
Medical technology company Laborie Medical Technologies, advised by Simpson Thacher & Bartlett LLP and Cooley LLP, unveiled plans Friday to acquire a postpartum uterine bleeding device from New Jersey-based healthcare company Organon for up to $465 million.
-
November 07, 2025
Solar Co. Pine Gate Hits Ch. 11 With $1B+ Debt, Sale Plan
Solar energy developer Pine Gate Renewables has filed for Chapter 11 protection in a Texas bankruptcy court with more than $1 billion in debt and a plan to sell its business during the case.
-
November 07, 2025
Wheaton Precious Metals To Buy US Gold Project For $670M
Canada-based Wheaton Precious Metals Corp. said Friday that it will add a U.S. gold mine from Waterton Gold LP to its portfolio in a $670 million cash deal.
-
November 07, 2025
UK Open To Fixes In Greencore's £1.2B Bakkavor Deal
The Competition and Markets Authority said Friday that it is likely to accept proposals by Greencore to sell its manufacturing plant for chilled sauces to get its £1.2 billion ($1.6 billion) deal for rival Bakkavor over the line.
-
November 06, 2025
CareFirst Urges Ban On J&J Character Talk At Stelara Trial
Health insurer CareFirst is asking a Virginia federal judge to bar Johnson & Johnson from promoting its "good character" to a jury that will weigh class claims of anticompetitive conduct and patent fraud to extend market protection on the blockbuster autoimmune drug Stelara.
-
November 06, 2025
Core Scientific Reaches $14.75M Deal With SPAC Investors
Bankrupt cryptocurrency miner Core Scientific has reached a $14.75 million agreement to settle proposed class action claims brought by an investor in the special purpose acquisition company that made a $4.3 billion deal to bring the miner public via merger.
-
November 06, 2025
Six Flags Faces Investor Suit Over Troubled Turnaround Bid
Amusement park giant Six Flags Entertainment Corp. faces a proposed investor class action alleging the company failed to effectively capitalize on its 2024 merger with another theme park operator, precipitating a "catastrophic" earnings miss in August.
-
November 06, 2025
Edwards Defends $945M Heart Valve Deal From FTC Challenge
Edwards Lifesciences urged a D.C. federal court to reject the Federal Trade Commission's bid to put its planned $945 million acquisition of JenaValve on hold, saying the deal will increase innovation and save the lives of thousands of people with a form of heart valve disease.
-
November 06, 2025
4 Firms Guide Go-Private Deal, $1.16B Casinos Sale
Gaming and hospitality company Golden Entertainment Inc.'s CEO Blake L. Sartini and affiliates have agreed to buy the company's operating assets, while real estate investment trust VICI Properties Inc. also agreed to pay $1.16 billion for a seven-property Golden Entertainment portfolio, Golden Entertainment and VICI announced Nov. 6.
-
November 06, 2025
AI Developer Made $100M By Dumping Tokens, Suit Says
A purported open-source artificial intelligence developer has been hit with a proposed class action accusing it of reaping over $100 million in ill-gotten gains by manipulating a token merger and breaching a covenant to develop AI tools in an "ethical and acceptable manner."
-
November 06, 2025
Charles Schwab Making $660M Push Into Private Markets
The Charles Schwab Corp. said Thursday it has agreed to acquire Forge Global Holdings Inc. in a transaction valued at approximately $660 million, in a deal guided by three firms that marks the financial services company's latest effort to dive deeper into private markets.
Expert Analysis
-
Litigation Inspiration: How To Respond After A Loss
Every litigator loses a case now and then, and the sting of that loss can become a medicine that strengthens or a poison that corrodes, depending on how the attorney responds, says Bennett Rawicki at Hilgers Graben.
-
The Metamorphosis Of The Major Questions Doctrine
The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.
-
Biotech Collaborations Can Ease Uncertainty Amid FDA Shift
As concerns persist that the U.S. Food and Drug Administration's reduced headcount will impede developments at already-strapped biotech companies, licensing and partnership transactions can provide the necessary funding and pathways to advance innovative products, say attorneys at Troutman.
-
Series
Playing Mah-Jongg Makes Me A Better Mediator
Mah-jongg rewards patience, pattern recognition, adaptability and keen observation, all skills that are invaluable to my role as a mediator, and to all mediating parties, says Marina Corodemus.
-
Business Court Bill Furthers Texas' Pro-Corporate Strategy
The Texas Legislature's recent bill to enhance corporate protections and expand access to the Texas Business Court by refining its jurisdictional standards is just the latest step in the state's playbook for becoming the new center of corporate America, say attorneys at Katten.
-
FTC Staff Cuts Unlikely To Curb Antitrust Enforcement Agenda
While Federal Trade Commission Chair Andrew Ferguson's recent commitment to reducing agency staff may seem at odds with the Trump administration's commitment to antitrust enforcement, a closer analysis shows that such reductions have little chance of derailing the president's efforts, say attorneys at Squire Patton.
-
Series
Law School's Missed Lessons: Navigating Client Trauma
Law schools don't train students to handle repeated exposure to clients' traumatic experiences, but for litigators practicing in areas like civil rights and personal injury, success depends on the ability to view cases clinically and to recognize when you may need to seek help, says Katie Bennett at Robins Kaplan.
-
Opinion
4 Former Justices Would Likely Frown On Litigation Funding
As courts increasingly confront cases involving hidden litigation finance contracts, the jurisprudence of four former U.S. Supreme Court justices establishes a constitutional framework that risks erosion by undisclosed financial interests, says Roland Eisenhuth at the American Property Casualty Insurance Association.
-
Takeaways From EU's Review Of Merger Control Guidelines
The European Commission’s newly launched consultation on the European Union’s merger guidelines will explore whether and how merger control should consider key policy objectives, such as innovation, investment incentives and security, say lawyers at Latham.
-
How Attys Can Use AI To Surface Narratives In E-Discovery
E-discovery has reached a turning point where document review is no longer just about procedural tasks like identifying relevance and redacting privilege — rather, generative artificial intelligence tools now allow attorneys to draw connections, extract meaning and tell a coherent story, says Rose Jones at Hilgers Graben.
-
Identifying Data Center Investment Challenges, Opportunities
The role of data centers is expanding, as are new opportunities for private capital investors, but there are issues to consider, including finance models and contract complexity, as well as power supply, cyber threat resilience and data sovereignty, say lawyers at Ropes & Gray.
-
Leveraging Diligence Findings For Better Life Sciences Deals
Life sciences parties should utilize due diligence strategically to review and draft deal documents, address issues identified during the diligence, and craft solutions to achieve the party's transactional goals, says Anna Zhao at Gunner Cooke.
-
IP Due Diligence Tips For AI Assets In M&A Transactions
Artificial intelligence systems' integration into business operations creates new considerations for intellectual property due diligence in mergers and acquisitions and financing transactions, and implementing a practical approach to identifying AI assets can help avoid litigation and losses, say Armin Ghiam and Senna Hahn at Hunton.
-
AbbVie Frees Taxpayers From M&A Capital Loss Limitations
The U.S. Tax Court’s June 17 opinion in AbbVie v. Commissioner, finding that a $1.6 billion break fee was an ordinary and necessary business expense, marks a pivotal rejection of the Internal Revenue Service’s position on the tax treatment of termination fees related to failed mergers or acquisitions, say attorneys at Holland & Knight.
-
Capital One Deal Approval Lights Up Path For Bank M&A
The federal banking regulators' recent approval of Capital One's acquisition of Discover signals the agencies' willingness to approve large transactions and a more favorable environment generally for bank mergers under the Trump administration, say attorneys at Arnold & Porter.